Bank of New York Mellon Corp - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 69 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$20,163
+8.9%
12,6810.0%0.00%
Q4 2022$18,514
-65.7%
12,681
-0.4%
0.00%
Q3 2022$54,000
+10.2%
12,7270.0%0.00%
Q2 2022$49,000
-90.6%
12,727
-88.3%
0.00%
Q1 2022$520,000
+29.4%
109,215
-0.7%
0.00%
Q4 2021$402,000
-53.6%
110,013
+1.9%
0.00%
Q3 2021$866,000
-22.3%
107,938
+9.8%
0.00%
Q2 2021$1,115,00098,2950.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders